Alpha 2.0
Login Register
» Authors » P C M Andel

P C M Andel

Explore the profile of P C M Andel including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 3
Citations 2
Followers 0
Related Specialties
General Medicine
Pharmacology
Oncology
Top 10 Co-Authors
M W J Stommel
I Q Molenaar
G A Cirkel
I H J T de Hingh
V E de Meijer
I W J M van Goor
R C Verdonk
H C van Santvoort
L A Daamen
M G Besselink
Published In
Trials
Ann Surg Oncol
Affiliations
Soon will be listed here.
Recent Articles
1.
Correction: Recurrent disease detection after resection of pancreatic ductal adenocarcinoma using a recurrence-focused surveillance strategy (RADAR-PANC): protocol of an international randomized controlled trial according to the Trials within...
Daamen L, van Goor I, Groot V, Andel P, Brosens L, Busch O, et al.
Trials . 2024 Jul; 25(1):456. PMID: 38970096
No abstract available.
2.
Prediction of Isolated Local Recurrence After Resection of Pancreatic Ductal Adenocarcinoma: A Nationwide Study
van Goor I, Andel P, Buijs F, Besselink M, Bonsing B, Bosscha K, et al.
Ann Surg Oncol . 2024 Jun; 31(12):8264-8275. PMID: 38937412
Background: Distinguishing postoperative fibrosis from isolated local recurrence (ILR) after resection of pancreatic ductal adenocarcinoma (PDAC) is challenging. A prognostic model that helps to identify patients at risk of ILR...
3.
Recurrent disease detection after resection of pancreatic ductal adenocarcinoma using a recurrence-focused surveillance strategy (RADAR-PANC): protocol of an international randomized controlled trial according to the Trials within Cohorts design
Daamen L, van Goor I, Groot V, Andel P, Brosens L, Busch O, et al.
Trials . 2024 Jun; 25(1):401. PMID: 38902836
Background: Disease recurrence remains one of the biggest concerns in patients after resection of pancreatic ductal adenocarcinoma (PDAC). Despite (neo)adjuvant systemic therapy, most patients experience local and/or distant PDAC recurrence...